 | • レポートコード：GIR-105X14223 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組換え型ベクターワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型ベクターワクチンの種類別市場規模（バリセラ、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他）、用途別市場規模（大人用、子供用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型ベクターワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：SANOFI PASTEUR S.A.、Novartis、GSK、CNBG、ChengDa Bio、Changsheng Life、Zhifei、SINOVAC BIOTECH、NuoCheng Bio、Hualan Bio、Kangtai ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：バリセラ、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他 ・用途別分析2016年-2026年：大人用、子供用 ・遺伝子組換え型ベクターワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型ベクターワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型ベクターワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型ベクターワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型ベクターワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Vector Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Vector Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Vector Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Vector Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others
Market segment by Application can be divided into
For Adult
For Child
The key market players for global Recombinant Vector Vaccines market are listed below:
SANOFI PASTEUR S.A.
Novartis
GSK
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Recombinant Vector Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Vector Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Vector Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 For Adult
1.3.3 For Child
1.4 Global Recombinant Vector Vaccines Market Size & Forecast
1.4.1 Global Recombinant Vector Vaccines Sales in Value (2016-2026))
1.4.2 Global Recombinant Vector Vaccines Sales in Volume (2016-2026)
1.4.3 Global Recombinant Vector Vaccines Price by Type (2016-2026) & (USD/Dose)
1.5 Global Recombinant Vector Vaccines Production Capacity Analysis
1.5.1 Global Recombinant Vector Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Vector Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Vector Vaccines Market Drivers
1.6.2 Recombinant Vector Vaccines Market Restraints
1.6.3 Recombinant Vector Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 SANOFI PASTEUR S.A.
2.1.1 SANOFI PASTEUR S.A. Details
2.1.2 SANOFI PASTEUR S.A. Major Business
2.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product and Services
2.1.4 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Recombinant Vector Vaccines Product and Services
2.2.4 Novartis Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Recombinant Vector Vaccines Product and Services
2.3.4 GSK Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 CNBG
2.4.1 CNBG Details
2.4.2 CNBG Major Business
2.4.3 CNBG Recombinant Vector Vaccines Product and Services
2.4.4 CNBG Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 ChengDa Bio
2.5.1 ChengDa Bio Details
2.5.2 ChengDa Bio Major Business
2.5.3 ChengDa Bio Recombinant Vector Vaccines Product and Services
2.5.4 ChengDa Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Changsheng Life
2.6.1 Changsheng Life Details
2.6.2 Changsheng Life Major Business
2.6.3 Changsheng Life Recombinant Vector Vaccines Product and Services
2.6.4 Changsheng Life Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Zhifei
2.7.1 Zhifei Details
2.7.2 Zhifei Major Business
2.7.3 Zhifei Recombinant Vector Vaccines Product and Services
2.7.4 Zhifei Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 SINOVAC BIOTECH
2.8.1 SINOVAC BIOTECH Details
2.8.2 SINOVAC BIOTECH Major Business
2.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Product and Services
2.8.4 SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 NuoCheng Bio
2.9.1 NuoCheng Bio Details
2.9.2 NuoCheng Bio Major Business
2.9.3 NuoCheng Bio Recombinant Vector Vaccines Product and Services
2.9.4 NuoCheng Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Hualan Bio
2.10.1 Hualan Bio Details
2.10.2 Hualan Bio Major Business
2.10.3 Hualan Bio Recombinant Vector Vaccines Product and Services
2.10.4 Hualan Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Kangtai
2.11.1 Kangtai Details
2.11.2 Kangtai Major Business
2.11.3 Kangtai Recombinant Vector Vaccines Product and Services
2.11.4 Kangtai Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Vector Vaccines Sales by Manufacturer
3.1 Global Recombinant Vector Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Vector Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Vector Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Vector Vaccines Manufacturer Market Share
3.4.2 Top 6 Recombinant Vector Vaccines Manufacturer Market Share
3.5 Global Recombinant Vector Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Vector Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Vector Vaccines Market Size by Region
4.1.1 Global Recombinant Vector Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Vector Vaccines Revenue by Region (2016-2026)
4.2 North America Recombinant Vector Vaccines Revenue (2016-2026)
4.3 Europe Recombinant Vector Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Vector Vaccines Revenue (2016-2026)
4.5 South America Recombinant Vector Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Vector Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Vector Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Vector Vaccines Revenue by Type (2016-2026)
5.3 Global Recombinant Vector Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Vector Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Vector Vaccines Revenue by Application (2016-2026)
6.3 Global Recombinant Vector Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Vector Vaccines Sales by Type (2016-2026)
7.2 North America Recombinant Vector Vaccines Sales by Application (2016-2026)
7.3 North America Recombinant Vector Vaccines Market Size by Country
7.3.1 North America Recombinant Vector Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Vector Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Vector Vaccines Sales by Type (2016-2026)
8.2 Europe Recombinant Vector Vaccines Sales by Application (2016-2026)
8.3 Europe Recombinant Vector Vaccines Market Size by Country
8.3.1 Europe Recombinant Vector Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Vector Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Vector Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Vector Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Vector Vaccines Market Size by Region
9.3.1 Asia-Pacific Recombinant Vector Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Vector Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Vector Vaccines Sales by Type (2016-2026)
10.2 South America Recombinant Vector Vaccines Sales by Application (2016-2026)
10.3 South America Recombinant Vector Vaccines Market Size by Country
10.3.1 South America Recombinant Vector Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Vector Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Vector Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Vector Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Vector Vaccines Market Size by Country
11.3.1 Middle East & Africa Recombinant Vector Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Vector Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Vector Vaccines Typical Distributors
12.3 Recombinant Vector Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Vector Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Vector Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. SANOFI PASTEUR S.A. Basic Information, Manufacturing Base and Competitors
Table 4. SANOFI PASTEUR S.A. Major Business
Table 5. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product and Services
Table 6. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Recombinant Vector Vaccines Product and Services
Table 10. Novartis Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Recombinant Vector Vaccines Product and Services
Table 14. GSK Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. CNBG Basic Information, Manufacturing Base and Competitors
Table 16. CNBG Major Business
Table 17. CNBG Recombinant Vector Vaccines Product and Services
Table 18. CNBG Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. ChengDa Bio Basic Information, Manufacturing Base and Competitors
Table 20. ChengDa Bio Major Business
Table 21. ChengDa Bio Recombinant Vector Vaccines Product and Services
Table 22. ChengDa Bio Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Changsheng Life Basic Information, Manufacturing Base and Competitors
Table 24. Changsheng Life Major Business
Table 25. Changsheng Life Recombinant Vector Vaccines Product and Services
Table 26. Changsheng Life Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Zhifei Basic Information, Manufacturing Base and Competitors
Table 28. Zhifei Major Business
Table 29. Zhifei Recombinant Vector Vaccines Product and Services
Table 30. Zhifei Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. SINOVAC BIOTECH Basic Information, Manufacturing Base and Competitors
Table 32. SINOVAC BIOTECH Major Business
Table 33. SINOVAC BIOTECH Recombinant Vector Vaccines Product and Services
Table 34. SINOVAC BIOTECH Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. NuoCheng Bio Basic Information, Manufacturing Base and Competitors
Table 36. NuoCheng Bio Major Business
Table 37. NuoCheng Bio Recombinant Vector Vaccines Product and Services
Table 38. NuoCheng Bio Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 40. Hualan Bio Major Business
Table 41. Hualan Bio Recombinant Vector Vaccines Product and Services
Table 42. Hualan Bio Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Kangtai Basic Information, Manufacturing Base and Competitors
Table 44. Kangtai Major Business
Table 45. Kangtai Recombinant Vector Vaccines Product and Services
Table 46. Kangtai Recombinant Vector Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Recombinant Vector Vaccines Sales by Manufacturer (2019-2021e) & (K Doses)
Table 48. Global Recombinant Vector Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Recombinant Vector Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Recombinant Vector Vaccines Production Capacity by Company, (K Doses): 2020 VS 2021
Table 51. Head Office and Recombinant Vector Vaccines Production Site of Key Manufacturer
Table 52. Global Recombinant Vector Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 53. Global Recombinant Vector Vaccines Sales by Region (2021-2026) & (K Doses)
Table 54. Global Recombinant Vector Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Recombinant Vector Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Recombinant Vector Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 57. Global Recombinant Vector Vaccines Sales by Type (2021-2026) & (K Doses)
Table 58. Global Recombinant Vector Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Recombinant Vector Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Recombinant Vector Vaccines Price by Type (2016-2021e) & (USD/Dose)
Table 61. Global Recombinant Vector Vaccines Price by Type (2021-2026) & (USD/Dose)
Table 62. Global Recombinant Vector Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 63. Global Recombinant Vector Vaccines Sales by Application (2021-2026) & (K Doses)
Table 64. Global Recombinant Vector Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Recombinant Vector Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Recombinant Vector Vaccines Price by Application (2016-2021e) & (USD/Dose)
Table 67. Global Recombinant Vector Vaccines Price by Application (2021-2026) & (USD/Dose)
Table 68. North America Recombinant Vector Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 69. North America Recombinant Vector Vaccines Sales by Country (2021-2026) & (K Doses)
Table 70. North America Recombinant Vector Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Recombinant Vector Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Recombinant Vector Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 73. North America Recombinant Vector Vaccines Sales by Type (2021-2026) & (K Doses)
Table 74. North America Recombinant Vector Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 75. North America Recombinant Vector Vaccines Sales by Application (2021-2026) & (K Doses)
Table 76. Europe Recombinant Vector Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 77. Europe Recombinant Vector Vaccines Sales by Country (2021-2026) & (K Doses)
Table 78. Europe Recombinant Vector Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Recombinant Vector Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Recombinant Vector Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 81. Europe Recombinant Vector Vaccines Sales by Type (2021-2026) & (K Doses)
Table 82. Europe Recombinant Vector Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 83. Europe Recombinant Vector Vaccines Sales by Application (2021-2026) & (K Doses)
Table 84. Asia-Pacific Recombinant Vector Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 85. Asia-Pacific Recombinant Vector Vaccines Sales by Region (2021-2026) & (K Doses)
Table 86. Asia-Pacific Recombinant Vector Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Recombinant Vector Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Recombinant Vector Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 89. Asia-Pacific Recombinant Vector Vaccines Sales by Type (2021-2026) & (K Doses)
Table 90. Asia-Pacific Recombinant Vector Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 91. Asia-Pacific Recombinant Vector Vaccines Sales by Application (2021-2026) & (K Doses)
Table 92. South America Recombinant Vector Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 93. South America Recombinant Vector Vaccines Sales by Country (2021-2026) & (K Doses)
Table 94. South America Recombinant Vector Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Recombinant Vector Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Recombinant Vector Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 97. South America Recombinant Vector Vaccines Sales by Type (2021-2026) & (K Doses)
Table 98. South America Recombinant Vector Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 99. South America Recombinant Vector Vaccines Sales by Application (2021-2026) & (K Doses)
Table 100. Middle East & Africa Recombinant Vector Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 101. Middle East & Africa Recombinant Vector Vaccines Sales by Country (2021-2026) & (K Doses)
Table 102. Middle East & Africa Recombinant Vector Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Recombinant Vector Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Recombinant Vector Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 105. Middle East & Africa Recombinant Vector Vaccines Sales by Type (2021-2026) & (K Doses)
Table 106. Middle East & Africa Recombinant Vector Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 107. Middle East & Africa Recombinant Vector Vaccines Sales by Application (2021-2026) & (K Doses)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Recombinant Vector Vaccines Typical Distributors
Table 111. Recombinant Vector Vaccines Typical Customers
List of Figures
Figure 1. Recombinant Vector Vaccines Picture
Figure 2. Global Recombinant Vector Vaccines Sales Market Share by Type in 2020
Figure 3. Varicella
Figure 4. Influenza
Figure 5. Polio
Figure 6. Hepatitis A
Figure 7. Rabies
Figure 8. BCG
Figure 9. Hepatitis B
Figure 10. Pertussis, Diphtheria, tetanus
Figure 11. Pneumococcal
Figure 12. Others
Figure 13. Global Recombinant Vector Vaccines Sales Market Share by Application in 2020
Figure 14. For Adult
Figure 15. For Child
Figure 16. Global Recombinant Vector Vaccines Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 17. Global Recombinant Vector Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. United States Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Canada Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Mexico Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Germany Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. France Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. United Kingdom Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Russia Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Italy Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. China Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Japan Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Korea Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. India Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Southeast Asia Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Australia Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Brazil Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Egypt Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Saudi Arabia Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. South Africa Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Turkey Recombinant Vector Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Global Recombinant Vector Vaccines Sales (2016-2026) & (K Doses)
Figure 38. Global Recombinant Vector Vaccines Production Capacity (2016-2026) & (K Doses)
Figure 39. Global Recombinant Vector Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 40. Recombinant Vector Vaccines Market Drivers
Figure 41. Recombinant Vector Vaccines Market Restraints
Figure 42. Recombinant Vector Vaccines Market Trends
Figure 43. Global Recombinant Vector Vaccines Sales Market Share by Manufacturer in 2020
Figure 44. Global Recombinant Vector Vaccines Revenue Market Share by Manufacturer in 2020
Figure 45. Recombinant Vector Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 46. Top 3 Recombinant Vector Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 47. Top 6 Recombinant Vector Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 48. Global Recombinant Vector Vaccines Sales Market Share by Region (2016-2026)
Figure 49. Global Recombinant Vector Vaccines Revenue Market Share by Region (2016-2026)
Figure 50. North America Recombinant Vector Vaccines Revenue (2016-2026) & (USD Million)
Figure 51. Europe Recombinant Vector Vaccines Revenue (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Recombinant Vector Vaccines Revenue (2016-2026) & (USD Million)
Figure 53. South America Recombinant Vector Vaccines Revenue (2016-2026) & (USD Million)
Figure 54. Middle East & Africa Recombinant Vector Vaccines Revenue (2016-2026) & (USD Million)
Figure 55. Global Recombinant Vector Vaccines Sales Market Share by Type (2016-2026)
Figure 56. Global Recombinant Vector Vaccines Revenue Market Share by Type (2016-2026)
Figure 57. Global Recombinant Vector Vaccines Price by Type (2016-2026) & (USD/Dose)
Figure 58. Global Recombinant Vector Vaccines Sales Market Share by Application (2016-2026)
Figure 59. Global Recombinant Vector Vaccines Revenue Market Share by Application (2016-2026)
Figure 60. Global Recombinant Vector Vaccines Price by Application (2016-2026) & (USD/Dose)
Figure 61. North America Recombinant Vector Vaccines Sales Market Share by Country (2016-2026)
Figure 62. North America Recombinant Vector Vaccines Revenue Market Share by Country (2016-2026)
Figure 63. North America Recombinant Vector Vaccines Sales Market Share by Type (2016-2026)
Figure 64. North America Recombinant Vector Vaccines Sales Market Share by Application (2016-2026)
Figure 65. Europe Recombinant Vector Vaccines Sales Market Share by Country (2016-2026)
Figure 66. Europe Recombinant Vector Vaccines Revenue Market Share by Country (2016-2026)
Figure 67. Europe Recombinant Vector Vaccines Sales Market Share by Type (2016-2026)
Figure 68. Europe Recombinant Vector Vaccines Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Recombinant Vector Vaccines Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Recombinant Vector Vaccines Revenue Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Recombinant Vector Vaccines Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Recombinant Vector Vaccines Sales Market Share by Application (2016-2026)
Figure 73. South America Recombinant Vector Vaccines Sales Market Share by Country (2016-2026)
Figure 74. South America Recombinant Vector Vaccines Revenue Market Share by Country (2016-2026)
Figure 75. South America Recombinant Vector Vaccines Sales Market Share by Type (2016-2026)
Figure 76. South America Recombinant Vector Vaccines Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Recombinant Vector Vaccines Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Recombinant Vector Vaccines Revenue Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Recombinant Vector Vaccines Sales Market Share by Type (2016-2026)
Figure 80. Middle East & Africa Recombinant Vector Vaccines Sales Market Share by Application (2016-2026)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …- 組換えハムスター卵巣細胞（CHO）B型肝炎ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chin…
- 世界の遺伝子組換え型B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のジフテリアワクチン市場 2021：企業別、地域別、種類・用途別 The Diphtheria Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- ヒト狂犬病ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course. Scope of the Report: This report focuses on the Human Rabies …